Form 8-K - Current report:
SEC Accession No. 0001493152-25-002913
Filing Date
2025-01-21
Accepted
2025-01-21 07:00:35
Documents
15
Period of Report
2025-01-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43961
  Complete submission text file 0001493152-25-002913.txt   272531

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hrow-20250117.xsd EX-101.SCH 3944
3 XBRL DEFINITION FILE hrow-20250117_def.xml EX-101.DEF 30369
4 XBRL LABEL FILE hrow-20250117_lab.xml EX-101.LAB 37183
5 XBRL PRESENTATION FILE hrow-20250117_pre.xml EX-101.PRE 27388
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6655
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 25540403
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)